Metabolism: hepatic and renal. Bioavailability: 70% to 90%. Half-life elimination: ~2 hours. Excretion: urine.
禁忌症
Hypersensitivity to somatropin or any component of the formulation; growth promotion in pediatric patients with closed epiphyses; acute critical illness due to increased complications/mortality following open heart or abdominal surgery, multiple accidental trauma, or acute respiratory failure; active malignancy; active proliferative or severe nonproliferative diabetic retinopathy.
It is recommended to inject subcutaneously before going to bed.
Children and teenagers:
(1) Growth hormone deficiency (GHD): 0.18 mg/kg weekly divided into equal doses 3, 6, or 7 days/week.
(2) Turner syndrome, Growth failure secondary to chronic kidney disease (CKD) : 1.4 mg/square meter of body surface area or 0.045~0.050 mg/kg of body weight.
(3) Growth retardation of low birth weight infants: 0.035 mg/kg body weight per day subcutaneous injection.
Adults: Growth hormone deficiency: ≤0.005 mg/kg/day; dose may be increased up to 0.01 mg/kg/day after 4 weeks; Maximum:1 mg/day.
小兒調整劑量
腎功能調整劑量
肝功能調整劑量
安定性
It can be maintained at 2-8 degrees for 28 days; It can be at 25 degrees for 7 consecutive days.